Growth Hormone Treatment for Non-GHD Disorders: Excitement Tempered by Biology.
Grimberg A, Hawkes CP.
J Clin Endocrinol Metab. 2024 Jan 18;109(2):e442-e454. doi: 10.1210/clinem/dgad417.
Non-viral vectors for RNA delivery.
Yan Y, Liu XY, Lu A, Wang XY, Jiang LX, Wang JC.
J Control Release. 2022 Feb;342:241-279. doi: 10.1016/j.jconrel.2022.01.008. Epub 2022 Jan 10.
Deep Learning in Medical Image Analysis.
Chan HP, Samala RK, Hadjiiski LM, Zhou C.
Adv Exp Med Biol. 2020;1213:3-21. doi: 10.1007/978-3-030-33128-3_1.
Exploring and comparing adverse events between PARP inhibitors.
LaFargue CJ, Dal Molin GZ, Sood AK, Coleman RL.
Lancet Oncol. 2019 Jan;20(1):e15-e28. doi: 10.1016/S1470-2045(18)30786-1.
Calcitonin gene-related peptide (CGRP): role in migraine pathophysiology and therapeutic targeting.
Wattiez AS, Sowers LP, Russo AF.
Expert Opin Ther Targets. 2020 Feb;24(2):91-100. doi: 10.1080/14728222.2020.1724285. Epub 2020 Feb 13.
Invasive Computational Psychiatry.
Saez I, Gu X.
Biol Psychiatry. 2023 Apr 15;93(8):661-670. doi: 10.1016/j.biopsych.2022.09.032. Epub 2022 Oct 8.
Solving mitochondrial mysteries.
Murphy E.
J Mol Cell Cardiol. 2015 Jan;78:1-2. doi: 10.1016/j.yjmcc.2014.11.016. Epub 2014 Nov 22.
The Next Generation of KRAS Targeting: Reasons for Excitement and Concern.
Akhave NS, Biter AB, Hong DS.
Mol Cancer Ther. 2022 Nov 3;21(11):1645-1651. doi: 10.1158/1535-7163.MCT-22-0356.
Emotional states affect steady state walking performance.
Homagain A, Ehgoetz Martens KA.
PLoS One. 2023 Sep 14;18(9):e0284308. doi: 10.1371/journal.pone.0284308. eCollection 2023.
Fear, excitement, and financial risk-taking.
Lee CJ, Andrade EB.
Cogn Emot. 2015;29(1):178-87. doi: 10.1080/02699931.2014.898611. Epub 2014 Mar 24.
